Medication info
Basirova Tablet (Acyclovir)

Basirova Tablet (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Hana Pharm Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 199702351 · Notified 1997.02.19 · Insurance code 657800830

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in severe primary infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. For recurrent infections, it is preferable to start treatment at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To determine the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for reassessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse neuropsychiatric reactions; therefore, exercise caution, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 the adult dose. There are currently no reliable data on prevention of herpes simplex virus infections in immunocompetent patients. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Hana Pharm Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Genital herpes
  • herpes simplex virus infection
  • shingles virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections that may occur initially in the genital area and for recurring skin and mucosal herpes simplex virus infections. It is also effective in treating shingles virus infections and is particularly helpful in alleviating pain during the acute phase. However, the effectiveness for postherpetic neuralgia has not yet been definitively proven. This medication can also be used to treat chickenpox in children over 2 years of age. Overall, it plays a crucial role in the treatment and prevention of viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in severe primary infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. For recurrent infections, it is preferable to start treatment at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To determine the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for reassessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse neuropsychiatric reactions; therefore, exercise caution, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 the adult dose. There are currently no reliable data on prevention of herpes simplex virus infections in immunocompetent patients. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used in patients who are allergic to this drug or any of its components. Caution is necessary when administering to patients with poor kidney function, as neurological side effects may occur. It should be used with caution in patients with impaired liver function, as the risk of worsening liver function exists. Special care should be taken when using it in infants and children, and it should only be used when absolutely necessary if safety has not been established. In elderly patients, the drug concentration may increase due to impaired kidney function, making side effects more likely, so dosages and intervals should be carefully adjusted. Severe allergic reactions such as anaphylactic shock can rarely occur, so if symptoms such as decreased blood pressure, difficulty breathing, or chest tightness arise, drug administration must be discontinued immediately, and appropriate treatment should be sought. Skin reactions such as rashes, fever, blisters, or urticarial eruptions can occur, and if such symptoms develop, the use of the drug should be discontinued, and medical consultation should be sought. Serious skin conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis can rarely occur, so careful observation of skin condition is important. Neurological side effects can manifest as disturbances of consciousness, confusion, hallucinations, seizures, drowsiness, and anxiety, particularly in elderly patients or those with renal impairment. Renal abnormalities including diminished kidney function, hematuria, and proteinuria may develop, so it is important to periodically monitor kidney status. Blood abnormalities such as leukopenia, anemia, and bleeding may occur, so regular blood tests are needed to check the condition. Liver-related side effects such as liver dysfunction, jaundice, or hepatitis may occur, thus liver function tests may be required. Gastrointestinal symptoms such as gastritis, nausea, vomiting, diarrhea, and abdominal pain may arise, and if these symptoms persist, drug use should be discontinued and medical consultation sought. Systemic symptoms such as fever, muscle weakness, malaise, and headache may occur, so observation of condition is critical. Arthralgia or myalgia may also occur. Cardiac-related side effects such as arrhythmia, chest pain, or blood pressure changes may rarely appear, requiring vigilance. Dysuria or urinary retention may rarely occur. Adequate hydration is necessary during the use of this medication, and especially with high doses, sufficient water should be consumed to prevent dehydration and reduce the risk of nephrotoxicity. It is effective to start treatment as soon as symptoms appear, preferably within 5 days for shingles and within 3 days for chickenpox. Patients with compromised immune function may require treatment in the form of intravenous injections. When driving a car or operating dangerous machinery, caution should be exercised considering the potential side effects of altered consciousness or drowsiness. When used in conjunction with certain drugs, the drug concentration may change, or the risk of side effects may increase, so it is essential to inform the healthcare provider of any other medications being taken. Pregnant women or those who may become pregnant should carefully weigh the benefits and risks of using this medication, and it is advisable to discontinue breastfeeding as the drug may be transferred into breast milk. In case of overdose, severe neurological abnormalities, renal failure, etc., might occur, and immediate medical attention is necessary.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 117 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • coordination dysfunction
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • lowered blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • increased serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • convulsions
  • drowsiness
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is important to keep it at room temperature away from direct sunlight. Room temperature generally refers to a temperature range between 15 degrees and 25 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.